Zoledronska kiselina

Zoledronska kiselina
Klinički podaci
Prodajno imeAclasta, Reclast, Zometa, Zometa Concentrate
Drugs.comacid.html Monografija
Način primeneIntravenozno
Farmakokinetički podaci
Poluvreme eliminacije146 h
Identifikatori
CAS broj118072-93-8 ДаY
ATC kodM05BA08 (WHO)
PubChemCID 68740
DrugBankDB00399 ДаY
ChemSpider61986 ДаY
ChEMBLCHEMBL924 ДаY
Hemijski podaci
FormulaC5H10N2O7P2
Molarna masa272,090
SMILES
  • OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
InChI
  • InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14) ДаY
  • Key:XRASPMIURGNCCH-UHFFFAOYSA-N ДаY

Zoledronska kiselina je organsko jedinjenje, koje sadrži 5 atoma ugljenika i ima molekulsku masu od 272,090 Da.[1][2][3][4][5]

Osobine

Osobina Vrednost
Broj akceptora vodonika 8
Broj donora vodonika 5
Broj rotacionih veza 4
Particioni koeficijent[6] (ALogP) -1,2
Rastvorljivost[7] (logS, log(mol/L)) 1,8
Polarna površina[8] (PSA, Å2) 172,7

Reference

  1. ^ Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S: Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture. N Engl J Med. 2007 Sep 26;. PMID 17878149
  2. ^ Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, Widmer A, Devogelaer JP, Kaufman JM, Jaeger P, Body JJ, Brandi ML, Broell J, Di Micco R, Genazzani AR, Felsenberg D, Happ J, Hooper MJ, Ittner J, Leb G, Mallmin H, Murray T, Ortolani S, Rubinacci A, Saaf M, Samsioe G, Verbruggen L, Meunier PJ: Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med. 2002 Feb 28;346(9):653-61. PMID 11870242
  3. ^ Durie BG, Katz M, Crowley J: Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005 Jul 7;353(1):99-102; discussion 99-102. PMID 16000365
  4. ^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709 Слободан приступ. PMID 21059682. doi:10.1093/nar/gkq1126.  уреди
  5. ^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889 Слободан приступ. PMID 18048412. doi:10.1093/nar/gkm958.  уреди
  6. ^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o. 
  7. ^ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t.  уреди
  8. ^ Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e.  уреди

Literatura

  • Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803. 
  • Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799. 

Spoljašnje veze

  • Zoledronic acid
  • п
  • р
  • у
Lekovi za tretman bolesti kostiju (M05)
BisfosfonatiKoštani morfogenetički proteiniDrugi
Inhibitor resorpcije (Ipriflavon) • Aluminijum hlorohidrat • Koštani agens dualnog dejstva (Stroncijum ranelat) • RANKL inhibitor (Denosumab) • Katepsin K inhibitor (Odanakatib)

M: BON/CAR

anat(t,c,f,k,f,u,p,l)/phys/devp

noco/cong/tumr, sysi/epon, injr

proc, lek(M5)


Molimo Vas, obratite pažnju na važno upozorenje
u vezi sa temama iz oblasti medicine (zdravlja).
Zoledronska kiselina na srodnim projektima Vikipedije:
Mediji na Ostavi
Podaci na Vikipodacima